Skip to content

Neuromodulation as a treatment for food addiction in obese individuals

Effect of transcranial random noise stimulation (tRNS) on food craving in obese individuals with food addiction

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12615000628549
Enrollment
28
Registered
2015-06-17
Start date
2015-07-01
Completion date
2016-06-30
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Functional brain imaging studies have shown dysfunctional neural activity in the cortical reward system network of obese individuals. Thus, a reasonable hypothesis would be that altering this pathological state using techniques of non-invasive neuromodulation may prove to be a therapeutic option. To date, no studies have used transcranial random noise stimulation (tRNS) in the treatment of obesity. Therefore, the aim of this study is to use (tRNS) to target the anterior cingulate cortex (ACC) as part of the ‘addictive network’ in 28 obese food-addicted individuals (as defined by the Yale Food Addiction Scale, YFAS) to investigate the effects on craving/wanting and brain activity.

Interventions

Group 1: placebo tRNS Group 2: active tRNS For tRNS: a) Dose administered: 1 mA for 10 minutes with 60 seconds ramp up and ramp down at the beginning and end of each stimulation session. b) Frequency of stimulation: 3 times a week for 2 weeks. c) Treatment will be administered by a trained Assistant Research Fellow d) Mode of administration: external head device (Starstim system- NE neuroelectrics) worn with electrodes on anterior cingulate cortex (4 cathodes at F7, T3, F8 and T4; 1 anode at F

Group 1: placebo tRNS Group 2: active tRNS For tRNS: a) Dose administered: 1 mA for 10 minutes with 60 seconds ramp up and ramp down at the beginning and end of each stimulation session. b) Frequency of stimulation: 3 times a week for 2 weeks. c) Treatment will be administered by a trained Assistant Research Fellow d) Mode of administration: external head device (Starstim system- NE neuroelectrics) worn with electrodes on anterior cingulate cortex (4 cathodes at F7, T3, F8 and T4; 1 anode at Fz) e) Monitoring adherence using Case Report Forms

Sponsors

Department of Medicine, University of Otago
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject)

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

aged 20-60, BMI more or equals 30, Scores equals to or more than 3 on the Yale Food Addiction Scale

Exclusion criteria

Major weight gain or loss in the last 6 months (5 kg or more), recent significant head injuries, psychiatric disorders, history of epilepsy, metal implants, recurring headache, previous bariatric surgery, previous diagnosis of eating disorder, females who are or intend to become pregnant, other health problems (diabetes, cancer, heart disease, uncontrolled hypertension)

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026